TRIM38 Suppresses the Progression of Colorectal Cancer via Enhancing CCT6A Ubiquitination to Inhibit the MYC Pathway
Advanced Science · 2025
DOI: 10.1002/advs.202411285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yue Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, P. R. China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Proto-Oncogene Proteins c-myc, Tripartite Motif Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation, Basic Research Program of Jiangsu Province, Jiangsu Key Medical Discipline.
Abstract (Originalsprache)
Emerging evidence reveals the pivotal function of tripartite motif protein (TRIM) in colorectal cancer (CRC). However, the precise function of TRIM38 and its underlying mechanism in CRC remains to be elucidated, especially regarding its putative ubiquitination function. Here, it is identified that TRIM38 is downregulated in CRC tissues by DNA hypermethylation of its promoter. Further analysis demonstrates that decreased TRIM38 is correlated with unfavorable clinical features and poor prognosis. Moreover, TRIM38 functions as a tumor suppressor by inhibiting cell proliferation, metastasis, and AOM/DSS‐induced tumorigenesis in CRC cells. Mechanistically, TRIM38 binds to the substrate protein CCT6A, leading to the degradation and K48‐linked ubiquitination of CCT6A at the K127/K138 residues. The elevation of CCT6A protein level caused by TRIM38 downregulation diminishes the degradation of c‐Myc protein, thereby activating the MYC pathway. The study elucidates a novel mechanism of TRIM38/CCT6A/c‐Myc axis regulating CRC, potentially offering a new therapeutic target for its treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, P. R. China.
- The First School of Clinical Medicine Nanjing Medical University, Nanjing, 210029, P. R. China.
- Colorectal Institute of Nanjing Medical University, Nanjing, 210029, P. R. China.
- Jiangsu Province Engineering Research Center of Colorectal Cancer Precision Medicine and Translational Medicine, Nanjing, 210029, P. R. China.
- Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu, 225000, P. R. China.
- The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, 215000, P. R. China.
ORCID-Profile: Yueming Sun
Förderung
- National Natural Science Foundation
- Basic Research Program of Jiangsu Province
- Jiangsu Key Medical Discipline
- Jiangsu Provincial Key Research and Development Program
Zitieren
APA
Zhang, Y., Tan, X., Wang, L., Ji, D., Zhang, C., Peng, W., Zhu, R., Wang, X., Zhou, J., Feng, Y., & Sun, Y. (2025). TRIM38 Suppresses the Progression of Colorectal Cancer via Enhancing CCT6A Ubiquitination to Inhibit the MYC Pathway. Advanced Science. https://doi.org/10.1002/advs.202411285
Vancouver
Zhang Y, Tan X, Wang L, Ji D, Zhang C, Peng W, et al. TRIM38 Suppresses the Progression of Colorectal Cancer via Enhancing CCT6A Ubiquitination to Inhibit the MYC Pathway. Advanced Science. 2025. doi:10.1002/advs.202411285
BibTeX
@article{Zhang2025,
author = {Zhang, Yue and Tan, Xinyu and Wang, Lu and Ji, Dongjian and Zhang, Chuan and Peng, Wen and Zhu, Renzhong and Wang, Xiaowei and Zhou, Jiahui and Feng, Yifei and Sun, Yueming},
title = {TRIM38 Suppresses the Progression of Colorectal Cancer via Enhancing CCT6A Ubiquitination to Inhibit the MYC Pathway},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202411285}
}
EUVIMED